Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05565079 · ClinicalTrials.gov registry record · Phase 4
Root Coverage Using ADM and Coronally Positioned Tunnel With or Without Enamel Matrix Derivative
A Phase 4 study, sponsored by University of Louisville.
- Completed
- Registry status
- Phase 4
- Development phase
- 24
- Enrollment target
NCT05565079 is a Phase 4 study that has completed, run by University of Louisville. The registered enrollment target is 24 participants.
The verdict
NCT05565079, a Phase 4 study, has completed, sponsored by University of Louisville.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 24 participants
- Enrollment target
Study Summary
24 patients will be treated with a coronally positioned tunnel with AlloDerm RTM with or without the addition of Enamel Matrix Derivative to compare the baseline and 6-month changes in recession defect coverage, clinical attachment levels, amount of keratinized tissue width, and soft tissue thickness.
Interventions
- BIOLOGICAL Regenerative tissue matrix and enamel matrix derivative
- BIOLOGICAL Regenerative tissue matrix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2022-10-06 |
| Est. Completion | 2024-10-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05565079
The ClinicalTrials.gov registry entry for NCT05565079 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Regenerative tissue matrix and enamel matrix derivative is the first listed.
NCT05565079 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05565079 about?
NCT05565079 is a clinical study titled "Root Coverage Using ADM and Coronally Positioned Tunnel With or Without Enamel Matrix Derivative". 24 patients will be treated with a coronally positioned tunnel with AlloDerm RTM with or without the addition of Enamel Matrix Derivative to compare the baseline and 6-month changes in recession defect coverage, clinical attachment levels, amount of keratinized tissue width, and soft tissue thicknes...
What is the current status of trial NCT05565079?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 24 participants. The study started on 2022-10-06. Estimated completion is 2024-10-30.
What interventions are being tested in trial NCT05565079?
The interventions under investigation include: Regenerative tissue matrix and enamel matrix derivative (BIOLOGICAL), Regenerative tissue matrix (BIOLOGICAL).
Who is sponsoring clinical trial NCT05565079?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.